This inventor holds 2 USPTO granted patents. Top assignee: Harvard College. Active years: 1995-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-1998
Title: Richard G Titus: Innovator in Vasodilatory and Immune Suppressing Peptides
Introduction
Richard G Titus is a notable inventor based in Needham, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of peptides that have potential therapeutic applications. With a total of 2 patents, his work focuses on proteins derived from the sand fly Lutzomyia longipalpis.
Latest Patents
Richard G Titus's latest patents include innovative discoveries related to vasodilatory and immune suppressant peptides. The first patent discloses proteins derived from the sand fly capable of inducing vasodilation in mammals. It also characterizes the proteins and nucleic acids encoding them. Additionally, this patent outlines a method for temporarily inactivating the immune system in a mammal by administering the Lutzomyia protein, CGRP, calcitonin, or active immune suppressing analogs thereof. The second patent similarly focuses on vasodilatory peptides from the salivary gland of the sand fly, detailing the proteins and their encoding nucleic acids, along with the method for immune system inactivation.
Career Highlights
Richard G Titus is affiliated with Harvard College, where he continues to engage in groundbreaking research. His work has implications for various medical applications, particularly in the fields of immunology and vascular biology.
Collaborations
Some of his notable coworkers include Heinz G Remold and Jose M Ribeiro, who have contributed to the research and development of his patented technologies.
Conclusion
Richard G Titus stands out as an influential inventor in the realm of biomedical innovations. His patents reflect a commitment to advancing medical science through the exploration of unique peptides.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
